| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/11/2008 | WO2008109110A3 System for regulating blood pressure |
| 12/11/2008 | WO2008105911A9 Crystallized oxalate decarboxylase and methods of use |
| 12/11/2008 | WO2008100384A3 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 12/11/2008 | WO2008088385A3 Peptides that enhance acetylcholinesterase expression |
| 12/11/2008 | WO2008087025A3 Specific therapy and medicament using integrin ligands for treating cancer |
| 12/11/2008 | WO2008079314A3 Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity |
| 12/11/2008 | WO2008069975A3 Methods of using f-spondin as a biomarker for cartilage degenerative conditions |
| 12/11/2008 | WO2008069965A3 Novel genes and proteins that home to developing microvessels |
| 12/11/2008 | WO2008069958A3 Substrate switched ammonia lyases and mutases |
| 12/11/2008 | WO2008069824A3 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| 12/11/2008 | WO2008068765A3 Compositions and methods for inhibiting hiv-1 replication and integrase activity |
| 12/11/2008 | WO2008066626A3 METHODS FOR THE TREATMENT OF Aβ RELATED DISORDERS AND COMPOSITIONS THEREFOR |
| 12/11/2008 | WO2008062481A3 Formulations of peg-interferon alpha conjugates |
| 12/11/2008 | WO2008057608A8 Synthetic peptide amides |
| 12/11/2008 | WO2008055254A3 Formulations and methods for oral delivery of proteins |
| 12/11/2008 | WO2008051689A3 Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 12/11/2008 | WO2008051421A3 Peptide-cytotoxic conjugates |
| 12/11/2008 | WO2008048466A3 Bone resorption disorders |
| 12/11/2008 | WO2008024919A3 Interferon antagonists, antibodies thereto, and associated methods of use |
| 12/11/2008 | WO2008002620A3 Cell model for alzheimer's disease pathology |
| 12/11/2008 | WO2007138336A3 Treatment of pain by single chain, polypeptide fusion protein |
| 12/11/2008 | WO2007130419A3 Histone deacetylase inhibitors for the treatment of neurodegeneration |
| 12/11/2008 | WO2007126457A3 Method and composition for treating and preventing tumor metastasis in vivo |
| 12/11/2008 | WO2007115182A3 Linear natriuretic peptide constructs |
| 12/11/2008 | WO2007115175A3 Cyclic natriuretic peptide constructs |
| 12/11/2008 | WO2007102936A3 Polynucleotides for production of farnesyl dibenzodiazepinones |
| 12/11/2008 | WO2007095113A3 Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists |
| 12/11/2008 | WO2007089690A3 Tat-042 and methods of assessing and treating cancer |
| 12/11/2008 | WO2007070659A3 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 12/11/2008 | WO2006073950B1 Nanoparticles for protein drug delivery |
| 12/11/2008 | WO2004105684A3 Combination therapy for proliferative disorders |
| 12/11/2008 | US20080306248 Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof |
| 12/11/2008 | US20080306212 Polymer conjugates of mutated neublastin |
| 12/11/2008 | US20080306104 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080306074 Compositions Comprising Addl Receptors, Related Compositions, and Related Methods |
| 12/11/2008 | US20080306010 Vaccine composition containing irradiated ovalbumin for the prevention and treatment of allergic disease |
| 12/11/2008 | US20080306009 Tetrapeptide Leu-Ala-Gly-Val derived from human chorionic gonadotropin; nitric oxide biosynthesis modulator |
| 12/11/2008 | US20080306008 Peptides for Use in the Treatment of Obesity |
| 12/11/2008 | US20080306007 Agents for prophylaxis or treatment of neurological related diseases and conditions |
| 12/11/2008 | US20080306006 MicroRna-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Solid Cancers |
| 12/11/2008 | US20080306005 Treatment of bone disorders with skeletal anabolic drugs |
| 12/11/2008 | US20080306004 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 12/11/2008 | US20080306003 Novel Compositions and Methods for Promoting, Inhibiting and Detecting Protein Entry Into Cells |
| 12/11/2008 | US20080306002 Combination Therapy for Preventing Angiogenesis |
| 12/11/2008 | US20080306001 Transcriptional modulation of extracellular matrix (ecm) of dermal fibroblasts |
| 12/11/2008 | US20080306000 Three-Dimensional Structures of TALL-1 and its Cognate Receptors and Modified Proteins and Methods Related Thereto |
| 12/11/2008 | US20080305999 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| 12/11/2008 | US20080305998 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR) |
| 12/11/2008 | US20080305997 Modulation Of Cd4+ T Cell Responses By A Tick Saliva Protein, Salp15 And Polypeptides Derived Therefrom |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | US20080305995 Royal Jelly Peptide and Composition Containing the Same |
| 12/11/2008 | US20080305994 Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye |
| 12/11/2008 | US20080305993 Use of C1 Inhibitor for the Prevention of Ischemia-Reperfusion Injury |
| 12/11/2008 | US20080305992 Glycopegylated erythropoietin |
| 12/11/2008 | US20080305991 Factor IX: remodeling and glycoconjugation of factor IX |
| 12/11/2008 | US20080305990 Method of Producing Fully Carbamylated Erythropoietin |
| 12/11/2008 | US20080305989 Peptides faciliatate non-invasive percutaneous or transdermal drug delivery of insulin, growth hormone, apomorphine, or PT-141 (peptide analogue of alpha -melanocyte-stimulating hormone) |
| 12/11/2008 | US20080305988 V-Like Domain Binding Molecules |
| 12/11/2008 | US20080305987 Sex-specific regulation of aging and apoptosis |
| 12/11/2008 | US20080305986 Multimers of Peptides |
| 12/11/2008 | US20080305985 Isosteric Transormation |
| 12/11/2008 | US20080305543 RNA interference pathway genes as tools for targeted genetic interference |
| 12/11/2008 | US20080305490 Amplification of human mdm2 gene in human tumors |
| 12/11/2008 | US20080305187 Use of Parathyroid Hormone for Treating Periodontal Disease and for Other Dental Applications |
| 12/11/2008 | US20080305186 Method and Composition for the Treatment of Cardiac Hypertrophy |
| 12/11/2008 | US20080305178 Use of a high molecular weight extracellular haemoglobin as a blood substitute |
| 12/11/2008 | US20080305174 Polymeric nanocapsules for use in drug delivery |
| 12/11/2008 | US20080305167 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080305152 Methods of Inducing Melanogenesis in a Subject |
| 12/11/2008 | US20080305151 Dipeptide-Comprising Composition for Oral Administration |
| 12/11/2008 | US20080305139 Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation |
| 12/11/2008 | US20080305131 Cancer Immunotherapy with Semi-Allogeneic Cells |
| 12/11/2008 | US20080305118 Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor |
| 12/11/2008 | US20080305112 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | US20080305109 Method of passive immunization |
| 12/11/2008 | US20080305108 Peptides of Il1 Beta and Tnf Alpha and Method Treatment |
| 12/11/2008 | US20080305107 Targeting slow-growing, relatively mutationally spared cancer stem line; early cancer treatment and reduce the likelihood of clinical relapse |
| 12/11/2008 | US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto |
| 12/11/2008 | US20080305103 Intraocular pressure-regulated early genes and uses thereof |
| 12/11/2008 | US20080305102 Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer |
| 12/11/2008 | US20080305101 Methods and Compositions Related to Clot Binding Compounds |
| 12/11/2008 | US20080305100 Activated Protein C Inhibits Undesirable Effects of Plasminogen Activator in the Brain |
| 12/11/2008 | US20080305099 degrades soluble and insoluble A beta so that it can prevent the accumulation of A beta in brain or reduce the accumulation; Alzheimer's disease and Down's syndrome |
| 12/11/2008 | US20080305098 Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor |
| 12/11/2008 | US20080305097 Use of Protease or a Protease Inhibitor for the Manufacture of Medicaments |
| 12/11/2008 | US20080305096 Method and composition for providing controlled delivery of biologically active substances |
| 12/11/2008 | US20080305092 Methods of treating autoimmune disease via CTLA-4IG |
| 12/11/2008 | US20080305091 Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity |
| 12/11/2008 | US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 12/11/2008 | US20080305085 Compositions And Methods For Stem Cell Expansion |
| 12/11/2008 | US20080305084 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 12/11/2008 | US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof |
| 12/11/2008 | US20080305081 Novel aminopyrimidine derivatives as PLK1 inhibitors |
| 12/11/2008 | US20080305080 Recombinant super-compound interferon |
| 12/11/2008 | US20080305079 Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity |
| 12/11/2008 | US20080305078 Soluble Il-17Rc Variant and Uses Thereof |
| 12/11/2008 | US20080305077 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| 12/11/2008 | US20080305076 Method of inducing memory b cell development and terminal differentiation |
| 12/11/2008 | US20080305075 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs |